Clinical presentation and follow‐up of patients with the attenuated phenotype of mucopolysaccharidosis type I
- 1 July 2005
- journal article
- Published by Wiley in Acta Paediatrica
- Vol. 94 (7) , 872-877
- https://doi.org/10.1111/j.1651-2227.2005.tb02004.x
Abstract
To review the heterogeneity and severity of the clinical features at the attenuated end of the mucopolysaccharidosis (MPS) type I disease spectrum. The course of disease in 29 patients with attenuated mucopolysaccharidosis I who attended the MPS clinic in Manchester, UK, was reviewed. For more than half of the patients, onset of symptoms was in the first 2 y of life, and the age at diagnosis ranged from 15 mo to 40 y. Joint stiffness, corneal clouding, umbilical hernia and recurrent ear, nose and throat symptoms were the commonest features at presentation. Patients experienced significant morbidity during the course of this inherited disease. Skeletal problems predominated and cardiac valve pathology, upper airway obstruction and hearing deficits were detected in a notable number of patients. Nerve decompression for carpal tunnel syndrome, cervical cord decompression, and grommet insertion for serous otitis media were the most frequent surgical interventions. Clinical presentation of attenuated ("non-Hurler") mucopolysaccharidosis type I is heterogeneous in time of onset and types of clinical features. A better understanding of the spectrum of disease and of the related disease progression will contribute to more accurate diagnosis, and patients will benefit from early intervention.Keywords
This publication has 15 references indexed in Scilit:
- Can mucopolysaccharidosis type I disease severity be predicted based on a patient’s genotype? A comprehensive review of the literatureGenetics in Medicine, 2003
- Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sourcesBone Marrow Transplantation, 2003
- Enzyme replacement therapy for the mucopolysaccharide storage disordersExpert Opinion on Investigational Drugs, 2002
- The frequency of lysosomal storage diseases in The NetherlandsHuman Genetics, 1999
- The mucopolysaccharidoses: a clinical review and guide to management.Archives of Disease in Childhood, 1995
- Molecular genetics of muccpolysaccharidosis type I: Diagnostic, clinical, and biological implicationsHuman Mutation, 1995
- Biochemical diagnosis of mucopolysaccharidoses: Experience of 297 diagnoses in a 15-year period (1977–1991)Journal of Inherited Metabolic Disease, 1993
- Structure and sequence of the human α-l-iduronidase geneGenomics, 1992
- Characteristics of leukocyte and plasma methylumbelliferyl-α-l-iduronide iduronidaseBiochemical Medicine and Metabolic Biology, 1989
- Mucopolysaccharidosis type I subtypes. Presence of immunologically cross-reactive material and in vitro enhancement of the residual alpha-L-iduronidase activities.Journal of Clinical Investigation, 1988